Low T Center Launches Women’s Hormone Health Services Nationwide

Audio By Carbonatix

HOUSTON--(BUSINESS WIRE)--Aug 11, 2025--

Low T Center, leader in personalized hormone optimization, is expanding its hormone care services to include women’s hormone replacement therapy (HRT), including in-clinic and self-inject testosterone replacement therapy. Beginning July 28, 2025, these services will be available at all clinic locations nationwide.

This expansion advances the accessibility of hormone care for women, reflecting a continued investment in precision medicine, clinical oversight, and individualized treatment plans supported by robust diagnostics.

Expanded Services for Women

• Women’s HRT – For the first time, female patients may receive hormone replacement therapy (estrogen, progesterone, and testosterone) in the forms of pellets, creams, and, in the case of testosterone, injections.
• In-Clinic Testosterone Injections for Women – As part of the Women’s HRT program, female patients may also receive testosterone injections, with the option of in-office injections or Self-Inject, a process in which patients receive pre-filled syringes of testosterone delivered to their doors. Each process is guided by providers and informed by comprehensive lab analysis and continuous monitoring.
• Comprehensive Medical Onboarding – Female patients can begin treatment after an in-depth medical evaluation that includes an Autonomic Nervous System (ANS) test, metabolic panel, and a comprehensive hormone panel. Unlike male patients, women may begin therapy immediately upon presenting at least one qualifying symptom and receiving provider confirmation.

Raising the Standard in Women’s Hormone Health

Developed in response to widespread clinical need, this program combines laboratory-grade diagnostics, expert clinical oversight, and flexible treatment delivery models, creating a new standard of care that prioritizes efficacy, safety, and long-term results.

“Every woman deserves a hormone therapy program that is data-driven, personalized, and aligned with her long-term health goals,” said Wayne Wilson, CEO of Low T Center and Founder and CEO of SynergenX. “This expansion reflects our commitment to making high-quality, individualized hormone care more accessible than ever to everyone who needs it.”

About Low T Center

Headquartered in Houston, TX, Low T Center operates a multi-state network of advanced hormone health and wellness clinics. Recognized for rigorous clinical standards and custom-dosed therapies, the organizations deliver evidence-based, provider-led care focused on optimizing vitality, performance, and well-being.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250811230226/en/

CONTACT: Media Contact:

Jordan Bailey

Marketing Communications Specialist, SynergenX / Low T Center

8326391569

jbailey@synergenxhealth.com

KEYWORD: UNITED STATES NORTH AMERICA TEXAS

INDUSTRY KEYWORD: WOMEN FITNESS & NUTRITION MEN OTHER HEALTH ALTERNATIVE MEDICINE HEALTH CONSUMER PHARMACEUTICAL GENERAL HEALTH

SOURCE: SynergenX

Copyright Business Wire 2025.

PUB: 08/11/2025 08:00 AM/DISC: 08/11/2025 08:00 AM

http://www.businesswire.com/news/home/20250811230226/en